Navigation Links
Quorum Review IRB Presents on Good Clinical Practice Essentials at MAGI’s 2013 Clinical Research Conference
Date:4/17/2013

Seattle, WA (PRWEB) April 17, 2013

Quorum Review IRB, the industry leader in central IRB services, announces Director of Regulatory Affairs and General Counsel Linda Coleman, JD, CIP, CHC, CHRC, as a presenter at MAGI’s 2013 Clinical Research Conference – East. This year MAGI East will be held in Boston, MA, May 5-8, 2013.

Ms. Coleman’s presentation, “Good Clinical Practice Essentials: What You Won’t Learn from the Regulations,” provides unique insights into timely GCP topics. The presentation covers recent guidance from the FDA as well as inspection and audit findings. Using real-life studies packed with practical information, Ms. Coleman’s workshop lays the groundwork for many topics covered in the meeting. The presentation takes place Sunday, May 5th at 9:30 a.m.-12:00 p.m.

Ms. Coleman has over a decade of legal expertise in clinical trial research and regulatory oversight. She joined Quorum Review in 2007 as the Director of Regulatory Affairs and today continues to serve that role in addition to the role of General Counsel, which she assumed early in 2011. In April 2012, Ms. Coleman was honored by Puget Sound Business Journal as “Outstanding Corporate Counsel for a Small Business” (<1000 employees), recognizing her legal expertise in research matters and contribution to education.

MAGI’s 2013 Clinical Research Conference is one of the fastest growing events in the clinical research industry. The conference offers an exceptional networking environment with over 90 sessions and workshops that provide practical tips in a coherent program for operations, regulatory compliance, contracts and budgets. More information about the 2013 conference is available on the MAGI website.

For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.

About Quorum Review IRB

Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10634274.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Quorum Review IRB to Present “eConsent and the iPad: a Case Study” at Global ACRP Conference
2. Quorum Review IRB Presents “IRB Review of Registries, Databases and Biobanking” at 2013 AAHRPP Conference
3. Quorum Review IRB Launches Site Enrollment Service
4. No Nonsense Muscle Building Review Examining Vince DelMonte’s Workout Program Revealed
5. Best 2013 Virginia Home Security System Companies Reviewed by SecurityPlanet.com
6. Instant Traffic App: Review Examining Travis Stephenson's Automated "Super App" Released
7. Brazil Butt Lift: Review Examining Leandro Carvalho's Workout Program Released
8. Holosync Solution: Review Examining the Centrepointe Research Institute’s Meditation Solution Revealed
9. 2013 NuvaRing Blood-Clotting Allegations Inquiries Eligible for Review by Resource4thePeople Attorneys
10. Fantasy Lover Formula: Review Examining System To Become "Her Fantasy Lover" Released
11. Jacksonsville FL Hearing Aid Reviews Made Available Online to Share the Stories of Local Residents that have Overcome Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... Goodcents Deli Fresh Subs ... the Lincoln, Neb. area this year. , The first new location will open ... location will open at 84th and Northern Lights Drive this fall. And the third ...
(Date:4/27/2017)... ... ... Are you investing in the safety of your friends and family? Each year, ... most of us assume this type of accident will never happen to us, the ... the time to learn how to respond effectively or prevent these accidents from occurring ...
(Date:4/26/2017)... ... 26, 2017 , ... Jump Technologies, Inc., an innovative software ... completed a round of funding to accelerate its growth strategies. The $3.5 million ... is a growth equity firm focused on investments in healthcare and technology companies. ...
(Date:4/26/2017)... ... April 26, 2017 , ... Journal of Oral Implantology – Tooth ... to overall dental health, including complications with speech, eating, and overcompensation of mouth due ... replace lost teeth. As the number of tooth replacements increase, it is imperative to ...
(Date:4/26/2017)... ... April 26, 2017 , ... CareSet Labs ... of e-prescribing as measured in Part D Medicare data. The dataset, called PaPR ... either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") data set ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Research and Markets has announced the ... Prospects: Addressing Production Complexities Through Risk Management and Quality ... ... and Market Prospects: Overcoming Production Complexities Through Risk Management ... the current trends in the global biosimilars market, with ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: